The Smart Infusion Pump market can be divided into distinct type segments that reflect the underlying delivery technology and clinical workflow. Volumetric pumps, which use peristaltic or piston mechanisms to dispense precise fluid volumes, dominate the market because they support a broad range of medication protocols and are compatible with most hospital IV sets. Syringe pumps, employing a motor‑driven syringe barrel, are favored for high‑precision, low‑volume infusions such as vasoactive drugs and chemotherapy, contributing a sizable niche share despite higher unit cost. Patient‑controlled analgesia (PCA) pumps integrate patient‑activated dosing with safety limits, driving growth in postoperative pain management and chronic disease settings. Elastomeric pumps, disposable devices that rely on stored elastic energy, address ambulatory and home‑care requirements, expanding the market’s peripheral segment. Finally, wearable smart pumps combine wireless connectivity with miniaturized reservoirs, enabling continuous infusion in mobile patients and supporting emerging tele‑health models. Collectively, these type categories account for the total market size, with volumetric pumps representing the largest proportion, followed by syringe and PCA pumps, while elastomeric and wearable solutions together capture the remaining growth potential.